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We have previously shown that HCR is a good candi-
date gene for psoriasis based on its location in the
PSORS1 locus, predicted secondary structure change
of the associated allele, and expression pattern. To un-
derstand better the function of HCR, we studied how
HCR expression is altered in hyperproliferative skin
diseases other than psoriasis and in cancers. We exam-
ined also its regulation by di¡erent cytokines, growth
factors, and antipsoriatic agents using quantitative RT-
PCR (TaqMan) analysis and its location by immuno-
staining of keratinocyte cultures. Compared to psoriasis,
HCR protein had a di¡erent distribution in chronic
dermatitis, pityriasis rubra pilaris, mycosis fungoides,
and chronic skin ulcers. In three of six grade III squa-
mous cell carcinomas of the skin, four of four adeno-
carcinomas of the lung, and two of two ductal breast
adenocarcinomas, positive cytoplasmic staining in can-
cer cells was detected. As in psoriasis, Ki67 did not co-
localize with HCR. In cell cultures, HCR staining was
detected perinuclearly in the cytoplasm and in the nu-
clei, suggesting that the protein may have a role in both
compartments. A 2-fold downregulation of HCR
mRNA expression was observed on stimulation with
interferon-c. Based on the observations that HCR is de-
tected in cancers of epithelial origin in Ki67-negative
areas and that interferon-c downregulates its expres-
sion, we suggest it to have an antiproliferative function.
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P
soriasis is a common chronic skin disorder character-
ized by keratinocyte hyperproliferation, in£ammatory
in¢ltrates, and neoangiogenesis. The fundamental
pathophysiology of this debilitating disease has re-
mained unknown. Several factors are known to di¡er
in psoriatic lesional skin compared to nonlesional or normal skin
such as cytokine expression pattern (Krueger et al, 1990; Nickolo¡
and Gri⁄ths, 1990), expression of integrins (Kellner et al, 1991),
and T cell activation molecules (Skov et al, 1997). Indeed, various
factors di¡er already in nonlesional psoriatic skin compared to
normal skin such as Th1-type cytokine mRNA levels (Uyemura
et al, 1993), integrin expression (Pellegrini et al, 1992; de Boer
et al, 1994), extracellular matrix components (Mondello et al,
1996; Bata-Csorgo et al, 1998; Chen et al, 2001), and the synthesis
rate of collagen I and III (Koivukangas et al, 1995). It is not known
whether the primary alteration in psoriasis resides in keratino-
cytes or is the result of activated T cells and autoimmunity (Bos
and De Rie, 1999; Ortonne, 1999). Genetic factors, immune de-
fense, extracellular matrix components, cytokines, growth fac-
tors, and environmental factors are all known to contribute to
the onset of psoriasis (Ortonne, 1999).
In several genetic association and linkage studies, the most im-
portant genomic region in psoriasis predisposition is PSORS1
near HLA-C in chromosome 6p.21 (Tiilikainen et al, 1980; Nair
et al, 1997; Trembath et al, 1997). By sequence analysis, the HCR
gene (a-helix coiled coil rod homolog) has been found between
HLA-C and corneodesmosin, another gene investigated as a pos-
sible candidate gene for psoriasis (Guerrin et al, 1998; Guillaudeux
et al, 1998; Allen et al, 2001). In our previous studies, we have
shown that HCR is highly polymorphic and has a psoriasis-
associated allele (HCRWWCC) in di¡erent populations (Asu-
malahti et al, 2000, 2002). The predicted structure of the risk allele
of HCR protein di¡ers from the wild-type allele, a¡ecting pos-
sibly also the antigenicity or biochemical properties of the protein
(Asumalahti et al, 2002).
We have previously shown that HCR protein is di¡erently
expressed in lesional psoriatic skin compared to normal skin
(Asumalahti et al, 2002). In normal and nonlesional psoriatic skin
the protein is con¢ned to basal keratinocytes. In lesional psoriatic
skin HCR expression is enhanced within nuclei and cytoplasm
not only basally but also suprabasally above dermal papillae,
showing attenuated expression in other parts of the epidermis.
Finally, staining for the cell proliferation marker Ki67 is more
pronounced in rete ridges, showing negative correlation to
HCR staining, suggesting that HCR has a role in keratinocyte
proliferation (Asumalahti et al, 2002). All these ¢ndings make
HCR a plausible candidate gene for psoriasis susceptibility.
The purpose of this study was to investigate HCR protein
expression in other hyperproliferative skin disorders with
similarities to psoriasis and to examine its expression and regula-
tion in vitro in normal and psoriatic keratinocytes. HCR expres-
sion was also studied in di¡erent cancers. Our results suggest that
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interferon-g (IFN-g) downregulates mRNA levels of HCR in
normal keratinocytes, suggesting a possible pathogenetic link
between the immune system and keratinocytes.We also demon-
strate that HCR expression di¡ers between di¡erent hyper-
proliferative skin disorders compared to psoriatic skin. In vitro
HCR expression is seen in both the cytoplasm and the nucleus.
MATERIALS AND METHODS
Tissues Formalin-¢xed, para⁄n-embedded specimens of lichen planus
(n¼ 6), lichenoid chronic dermatitis (neurodermatitis) (n¼ 3), atopic
dermatitis (n¼ 8), mycosis fungoides (n¼ 3), pityriasis rubra pilaris
(n¼ 6), chronic ulcers (n¼ 7), ichthyosis vulgaris (n¼ 4), Morbus Bowen
(n¼ 4), basal cell carcinoma (n¼ 6), squamous cell carcinoma (SCC) (grI
n¼ 2, grII n¼ 5, grIII n¼ 6), and extramammary Paget’s disease (n¼ 3)
were obtained from the Department of Dermatopathology, University of
Helsinki. The diagnoses were con¢rmed by an experienced derma-
topathologist (A-L K). Specimens of lung adenocarcinoma (n¼ 4), lung
SCC (n¼ 2), ductal adenocarcinoma of the breast (n¼ 2), mucinous
(n¼1), serous (n¼ 2) ovarial cancers, colon carcinoma (n¼ 6), esophageal
adenocarcinoma (n¼ 3), and SCC (n¼ 6) were obtained from the
Department of Pathology, University of Helsinki, Finland. The study was
approved by the corresponding Ethical Committee and followed the
Declaration of Helsinki Guidelines.
Immunohistochemistry Immunostainings of tissue sections and
cultured keratinocytes were performed using the avidinbiotin
peroxidase complex technique (Vectastain ABC Kit,Vector Laboratories,
Burlingame, CA, for HCR and b-catenin; and StreptABComplex/HRP
Duet (Mouse/Rabbit) Kit, Dako, A/S Glostrup, Denmark, no. K0492, for
Ki67) (Saarialho-Kere et al, 2002). Aminoethylcarbazole or diamino-
benzidine were used as chromogenic substrates. Tissue sections were
pretreated with trypsin (10 mg per ml; HCR) or by antigen retrieval
(Ki67, b-catenin). The antibodies included polyclonal anti-HCR
(concentration 4 mg per ml) (Asumalahti et al, 2002), polyclonal anti-Ki67
(dilution 1:200, A047, Dako) as a marker for cell proliferation (Cattoretti
et al, 1992), and b-catenin (1:1000, C19220, Transduction Laboratories,
Lexington, KY). Ki67 immunohistochemistry was performed on sections
serial to those used for HCR. The tissues were counterstained with
hematoxylin. Controls for HCR were performed with preimmune sera
(concentration 10 mg per ml) or normal rabbit immunoglobulin
(immunostaining of the cells) and tissue sections of psoriatic skin were
used in all the experiments as positive internal controls.
Cell culture models Normal human keratinocytes were isolated from
adult skin obtained from reductive mammoplasties (Rechardt et al, 2000).
Subcutaneous fat and deep dermis were removed, and the remaining tissue
was incubated overnight at 0.25% trypsin in solution A (Gibco BRL, Life
Technologies). Following the incubation, keratinocytes were scraped o¡
from the epidermis with a scalpel and suspended in keratinocyte growth
medium (KGM, Gibco), supplemented with 5 ng per ml epidermal
growth factor and 50 mg per ml bovine pituitary extract (supplied by the
vendor), and containing 2% decalci¢ed fetal bovine serum. Keratinocytes
were maintained in KGM supplemented with epidermal growth factor and
bovine pituitary extract until con£uency.
Psoriatic lesional and nonlesional keratinocyte cell lines were established
from psoriatic plaque lesions and adjacent normal looking skin from four
patients at Oulu University Hospital. Cell lines were cultured in calcium-
free keratinocyte basal medium 2 (KBM-2, Clonetics, BioWhittaker,
Walkersville, MD), as previously described (Karvonen et al, 2000),
containing 1% penicillinstreptomycin and supplemented with bovine
pituitary extract, human epidermal growth factor, insulin, hydrocortisone,
transferrin, epinephrine, gentamicin sulfate, and amphotericin B (all from
Clonetics). Cells were grown on cell culture dishes. Normal, nonlesional,
and lesional keratinocytes in passages 2^3 were grown on Laboratory-Tec
chamber slides in calcium-free KBM-2 medium (Clonetics) for
comparison of HCR protein expression between these cell lines. Normal
keratinocytes were also grown in KGM (Gibco BRL) or Dulbecco’s
modi¢ed Eagle’s medium (Ca2þ 1.8 mM) (Gibco BRL) for 2 d and ¢xed
with formalin for immunostaining.
Quantitative expression assays To study the regulation of HCR
expression, normal keratinocytes (passages 2^4) were seeded in 24-well
plates and allowed to attach for 24 h. Then the cells were washed with
phosphate-bu¡ered saline, kept in medium without supplements
overnight, and treated with human INF-g (1 ng per ml, Promega,WI, or
10^100 U per ml, Roche Molecular Biochemicals, Mannheim, Germany),
tumor necrosis factor a (TNF-a, 10 ng per ml, Sigma, St Louis, MO),
epidermal growth factor (EGF, 10 ng per ml, Sigma), phorbol 12-
myristate 13-acetate (PMA, 10 ng per ml, Sigma), transforming growth
factor b (TGF-b, 10 ng per ml, Sigma) or TGF-a (30 ng per ml, Sigma),
keratinocyte growth factor (KGF, 10 ng per ml, Sigma), insulin growth
factor 1 (IGF-1, 100 ng per ml, R&D Systems, Minneapolis, MN),
lipopolysaccharide (LPS, 2.5 mg per ml, Sigma), vascular endothelial
growth factor (VEGF, 10 ng per ml, R&D Systems), basic ¢broblast
growth factor (bFGF, 10 ng per ml, Sigma), interleukin-1b (IL-1b, 5 U
per ml, Roche Molecular Biochemicals), interleukin-10 (IL-10, 10 ng per
ml, R&D Systems), retinoic acid (106 M, Sigma), 1,25-(OH)2 D3
(calcitriol, 107 M, Sigma), or dexamethasone (105 M, Sigma). After 24 h
and 48 h total RNAwas extracted from the cells.
Normal keratinocytes were grown in both low Ca2þ KGM (0.09 mM)
and in KGM with added CaCl2 (Ca
2þ 1.8 mM) to study the e¡ect of
keratinocyte di¡erentiation on HCR expression, and total RNA was
extracted after 24 h. To study the e¡ect of con£uency, normal
keratinocytes were seeded in 24-well plates at four di¡erent densities and
total RNAwas extracted when the most densely seeded keratinocytes grew
con£uently (other con£uencies: 70%, 50%, 20%).
PCR primers (forward 50 -GCCCACCAGGGAGTCCATA-30 and
reverse 50 -GGCTTCACTCAGGTCCTGCA-30) and a probe (AAGGGT
CCCTCTCTGTCCTGCTCG) (PE Biosystems, Warrington, UK) for
HCR were designed using the computer program Primer Express
(Applied Biosystems, Foster City, CA). The HPLC puri¢ed £uorogenic
probe contained a reporter dye (FAM) covalently attached at the 50 end
and a quencher dye (TAMRA) covalently attached at the 30 end. Pre-
developed TaqMan assay reagents for endogenous control human
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or b-actin labeled
with VIC reporter dye (Applied Biosystems) were used for ampli¢cation
of control genes.
Total cellular RNA was isolated from normal keratinocytes using the
RNAeasy Miniprep-Kit (Qiagen, Chatsworth, CA) according to the
manufacturer’s instructions. RNA was then reverse transcribed to cDNA
with TaqMan Reverse Transcription Reagents (Applied Biosystems) and
used as template in PCR. Real-time quantitative PCR assays were
performed with the ABI PRISM 7700 Sequence Detector System
(Applied Biosystems) (Rechardt et al, 2000). PCR ampli¢cations were
performed in a total volume of 20 mL, containing 5 mL cDNA sample, 10
mL TaqMan Universal PCR Master Mix (Applied Biosystems), 100 nM of
each primer, and 100 nM of £uorogenic probe. The predesigned GAPDH
or b-actin endogenous control reagents were used for normalization on the
same samples. MicroAmp Optical 96-Well Reaction Plates and Optical
Caps (Applied Biosystems) were used in reactions. Reaction conditions
were as follows: 2 min at 501C and 10 min at 941C, followed by a total of
40 cycles of 15 s at 941C and 1 min at 601C.
Statistical analysis Statistical signi¢cance of the di¡erences in mRNA
expression levels in TaqMan analyses was calculated using the unequal,
two-tailed, odd t test.
RESULTS
HCR protein in hyperproliferative skin disorders Expression
of the HCR protein was studied by immunohistochemistry
using polyclonal antibodies. To examine whether keratinocyte
hyperproliferation and acanthosis as such a¡ect HCR expression,
samples of chronic eczema, chronic skin ulcers, and lichenoid
chronic dermatitis were stained. In contrast to psoriasis, where
HCR is expressed basally above the dermal papillae at sites
where the epidermal layer is at its thinnest, much weaker
expression of HCR was seen in the eczema and lichenoid
samples (Fig 1a, b, and d, e). In ¢ve of eight samples of chronic
eczema, occasional positive staining of the nuclei could be seen
and in only two samples was there some basal cytoplasmic
staining (Fig 1d). In chronic skin ulcers, no positive kera-
tinocytes were detected (data not shown). In one of three
lichenoid chronic dermatitis samples occasional positive cyto-
plasmic and nuclear staining basally above the dermal papillae
was detected (Fig 1e).We performed HCR immunoanalysis also
on six samples of lichen planus, aT-cell-mediated, acanthotic, and
hyperkeratotic disorder, like psoriasis, often characterized by
substantial disruptions in the basement membrane zone
(Giannelli et al, 1996). In one of these samples (one of six) there
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was staining in nuclei and in two (two of six) some cytoplasmic
staining in keratinocytes (Fig 1f). Mycosis fungoides, which is
characterized by milder acanthosis and lymphocyte, but not
neutrophil, in¢ltrations, showed no staining in keratinocytes
(Fig 1g). Also in four samples of ichthyosis vulgaris and in six
samples of pityriasis rubra pilaris only occasional nuclei stained
positively (four of four and two of six, respectively). The staining
in all the samples studied showed no speci¢c features or HCR
over-expression (Fig 1dg). Although the immunohistochemical
data on para⁄n sections are semiquantitative, our results overall
revealed a consistently di¡erent pattern of HCR expression in
psoriasis compared to other hyperproliferative disorders.
HCR in cancers No immunosignal for HCRwas detected in
Bowen’s disease, basal cell carcinomas, or extramammary Paget’s
disease. All grade I and II SCC were negative. In three of six
grade III SCC, there was positive cytoplasmic staining in cancer
cells either at the edge or in the middle of the tumor (Fig 2e).
Samples of SCC of the lung (two of two) showed no HCR
expression by immunohistochemistry. Interestingly, staining was
evident in four of four adenocarcinomas of the lung (Fig 2a).
Furthermore, in two ductal adenocarcinomas of the breast (two
of two), cytoplasmic HCR staining was detected (Fig 2c). Ki67
was positive in the adjacent, but not in the same, cells (Fig 2b, d).
This di¡erence in adenocarcinoma versus SCC expression
prompted us to perform immunohistochemistry also in eso-
phageal adenocarcinomas and SCC. Esophageal adenocarci-
nomas (three of three) did not show any over-expression of
HCR; also six of six esophageal SCC were negative. One
mucinous ovarial carcinoma showed staining in cancer cells in
the epithelium, and two of two serous ovarial carcinomas did
not stain. Six of six colon carcinomas remained negative as well
as normal colon epithelium (two of two).
HCR in psoriatic lesional, nonlesional, and normal
keratinocytes in culture When cells cultured on chamber
slides were stained for HCR, staining was detected intensively
in the nuclei of the psoriatic lesional keratinocytes with also
fainter staining in the cytoplasm (Fig 3c). Normal human
keratinocytes showed marked perinuclear staining (Fig 3a). The
immunopositivity was most obvious in the migratory normal
and psoriatic keratinocytes, in areas where the cells did not grow
in con£uency (Fig 3ad). Interestingly, HCRwas expressed also
in psoriatic skin in vivo by keratinocytes showing absent
membranous b-catenin staining, suggesting abnormal adhesion
(Fig 1b, c). The nonlesional keratinocytes stained positively in
the cytoplasm and the nucleus (Fig 3b). The staining pattern was
the same independent of the calcium concentration in which the
normal keratinocytes had been grown. The preimmune and
normal rabbit IgG control stainings were negative (Fig 3e, f).
Expression of HCR is downregulated by IFN-c in primary
human keratinocytes To study the regulation of HCR, we
cultured normal keratinocytes, stimulated them with di¡erent
cytokines, growth factors, and antipsoriatic agents, and used
quantitative real-time PCR to measure HCR mRNA levels.
Interestingly, a reproducible 2-fold downregulation of HCR
mRNA expression was observed on stimulation with IFN-g for
24 h (Fig 4). To con¢rm these results, we did the same
Figure1. Distribution of HCR protein in psoriasis and other hyper-
proliferative dermatoses. (a) In psoriasis HCR is expressed in keratino-
cytes above dermal papillae at sites where the epidermal layer is at its
thinnest. (b) Another psoriasis lesion demonstrating cytoplasmic HCR
expression basally and suprabasally. (c) b-catenin staining in an adjacent
section. Arrows depict corresponding regions. Immunosignal for HCR
protein in (d) chronic eczema, (e) lichenoid chronic dermatitis, ( f ) lichen
planus (occasional cells with cytoplasmic staining are seen), and (g) mycosis
fungoides (nonspeci¢c signal in granular cell layer). Scale bars: (a), (e) 50
mm; (bd), ( f ), (g) 25 mm.
Figure 2. HCR and Ki-67 immunostaining in breast and lung
adenocarcinoma and in cutaneous SCC. (a) Cytoplasmic staining for
HCR protein in epithelial cancer cells of a lung adenocarcinoma. (b)
Immunostaining for Ki67 in an adjacent section. (c) Staining for HCR
protein in cancer cells in a ductal breast adenocarcinoma. (d ) Immunos-
taining for Ki67 in a serial section. Arrows mark corresponding regions. (e)
Cutaneous SCCwith HCR positive cancer cells at the invading front. Scale
bars: 50 mm.
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experiment with two IFN-g products from di¡erent companies
and also used two standard genes, human GAPDH and human
b-actin. The result was independent of the IFN-g and control
gene used. p-values in t tests for downregulation were 0.00749
and 0.00285 (1 ng per ml from Promega, compared to GAPDH
and b-actin, respectively) and 0.00016 and 0.00097 (10 U from
Roche, compared to GAPDH and b-actin, respectively) and the
di¡erence remained signi¢cant after Bonferroni correction for 16
substances tested (Fig 4). When normal keratinocytes were
stimulated for either 24 or 48 h with TNF-a, EGF, PMA,TGF-
a, TGF-b, KGF, bFGF, VEGF, IGF-1, LPS, IL-1b, IL-10, 1,25-
(OH)2 D3 (calcitriol), dexamethasone, or retinoic acid, no e¡ects
were noted (data not shown). Stromelysin-2 and ISG12, which
can be induced by EGF and IFN-g, respectively, in cultured
keratinocytes, were used as positive controls as described
previously and were induced as expected (data not shown)
(Gjermandsen et al, 2000; Rechardt et al, 2000).
Normal keratinocytes grown in low or high Ca2þ did not
di¡er in their expression levels (data not shown).We also seeded
normal keratinocytes on 24-well plates in di¡erent densities to
see the possible e¡ect of con£uency on the HCR expression, but
no such di¡erence could be noted.
DISCUSSION
Genetic factors have been shown in several association and link-
age analyses to play an important role in the pathobiology of
psoriasis: PSORS1 confers a signi¢cant risk for disease, estimated
to account for between 35% and 50% of the familial clustering
observed in psoriasis (Tiilikainen et al, 1980; Asahina et al, 1991;
Enerbck et al, 1997; Mallon et al, 1997; Nair et al, 1997; Trembath
et al, 1997; Burden et al, 1998; Lee et al, 2000).We have previously
shown that one of the known genes in this region, HCR, is
highly polymorphic and has a disease-associated allele that is pre-
dicted to change the secondary structure of HCR protein and
that is di¡erently expressed in psoriasis compared to normal skin
(Asumalahti et al, 2000, 2002). As a newly identi¢ed gene, how-
ever, the function of HCR is unknown.
Our results herein demonstrate that HCR protein is expressed
in psoriatic lesions above the tips of dermal papillae basally and
suprabasally in keratinocytes in a distinct manner, but in other
hyperproliferative, in£ammatory skin disorders this pattern of
staining is not observed. On the contrary, the staining resembles
more the staining seen in normal skin with faint basal cytoplas-
mic or scattered nuclear immunopositivity. This suggests that
HCR might have a speci¢c role in psoriasis, separate from mere
hyperproliferation, in£uencing keratinocyte growth or di¡eren-
tiation or antigenicity.
Interestingly, we found that HCR protein is expressed in dif-
ferent cancers of epidermal origin. In particular, the staining was
evident in all investigated samples of adenocarcinoma of the lung
and breast. As in the case of psoriasis, the hyperproliferation mar-
ker Ki67 was not expressed by the same cells. Also cancer cells in
mucinous ovariocarcinoma were HCR positive. Of skin cancers,
only some of the grade III SCC showed HCR protein scattered
in di¡erent parts of the tumor, suggesting that some epidermal
cells are induced to produce HCR when the tumor becomes
more dedi¡erentiated. It is known that skin cancers hardly ever
arise in psoriatic plaques, in contrast to lesions of many other skin
diseases, due to the putative senescence of keratinocytes in the
mid and upper levels of the psoriatic plaque (Nickolo¡, 2001).
At the cellular level, we demonstrate here that HCR protein is
more pronounced in the nucleus in lesional keratinocytes, but
can be seen also in the cytoplasm. In normal keratinocytes as in
nonlesional keratinocytes the protein is located most intensely
perinuclearly. This suggests that HCR protein may have roles
in both the nucleus and cytoplasm. Keratinocyte di¡erentiation
induced by increased calcium concentration of the keratinocyte
growth medium in vitro did not a¡ect the staining pattern seen
in undi¡erentiated normal keratinocytes. This result was further
con¢rmed by growing normal keratinocytes and analysing their
mRNA levels by TaqMan analysis. The con£uency of normal
keratinocytes did not a¡ect the expression of HCR at the
mRNA level either. In cell culture, however, particularly cells
without contact to their neighbors were HCR positive, suggest-
ing that adhesion may in£uence HCR expression (Fig 3). This
Figure 3. HCR immunostaining in keratinocytes cultured in KGM
(ac) or in Dulbecco’s modi¢ed Eagle’s medium (d). In (a) primary
human keratinocytes, (b) nonlesional keratinocytes, and (c) lesional kerati-
nocytes, both nuclear and cytoplasmic staining is seen. (d) Immunopositiv-
ity was most obvious in the migratory keratinocytes not growing in
con£uency. (e), ( f ) The corresponding negative preimmune controls for
(a)(d). (a), (b), (d), and (e) were counterstained with hematoxylin; no
counterstaining was used in (c) and ( f ) to better demonstrate the nuclear
staining. Scale bars: (a), (c)( f ) 25 mm; (b) 12.5 mm.
Figure 4. Expression of HCR is downregulated in primary human
keratinocytes stimulated by IFN-c. Keratinocytes were cultured in
KGM and treated with indicated concentrations of IFN-g as described in
Materials and Methods. Cells without treatment were used as controls. Total
RNAwas extracted, reverse transcribed, and analyzed by real-time quanti-
tative RT-PCR (TaqMan) using GAPDH as an endogenous control.
Results are shown relative to mRNA levels from control cells, assigned
the value 1. Error bars: mean SD.
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was substantiated by ¢ndings of absent b-catenin staining in
HCR positive cells in psoriatic skin (Fig 1b, c).
To understand the regulation of HCR, we measured mRNA
changes with quantitative RT-PCRusingTaqMan in normal ker-
atinocytes stimulated by di¡erent cytokines. Of many possible
cytokines and growth factors known to be associated with psor-
iasis, only IFN-g statistically signi¢cantly downregulated HCR
at the mRNA level. IFN-g is aTh1-related cytokine, highly rele-
vant in psoriasis (Zhou et al, 2003). It is produced byT lympho-
cytes and over-expressed in lesional psoriatic skin, stimulating
psoriatic keratinocytes to produce keratin 17 via IL-1 production
(Wei et al, 1999). Injected into normal skin, IFN-g induces a lesion
clinically and histologically indistinguishable from psoriatic
lesions (Barker et al, 1993). Our results suggest a hypothesis that
IFN-g might downregulate HCRwhere activated T lymphocytes
accumulate, which in turn would contribute to keratinocyte
hyperproliferation. This model should be tested with speci¢cally
designed quantitative experiments, and further studies are needed
to evaluate the regulation of HCR protein in lesional keratino-
cytes. There are clear suggestions that normal and lesional kerati-
nocytes may behave di¡erently in response to modulators, and
the responses may furthermore di¡er in vivo and in vitro. For
example, in vitro experiments have suggested that IFN-g stimu-
lates the growth of psoriatic keratinocytes, whereas it is antiproli-
ferative in normal keratinocytes (Nickolo¡, 1991).
In conclusion, our results show that HCR is expressed in psor-
iasis in a pattern that is di¡erent from other hyperproliferative
skin diseases. In cancers of epithelial origin HCR is detected in
areas that are not Ki67 positive as seen also in psoriasis. HCR
staining is seen both in the nucleus and cytoplasm of cultured
keratinocytes, suggesting that the protein may have a role in both
compartments. Finally, we demonstrate that a T lymphocyte cy-
tokine, IFN-g, downregulates HCR expression, which might
contribute to a possible antihyperproliferative role for HCR.
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